Fred R. Hirsch
Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine
Grants
No NSF/NIH grants on record.
Career Trajectory
Research Cluster Map
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Potential Collaborators
Recent Publications
Last 2 years · showing 20 of 40Mitochondrial DNA in Lung Cancer: from biology to clinical implications
Critical Reviews in Oncology/Hematology · 2026-06-01
Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments
Cancer Research · 2025-12-18
Bridging the gap in lung cancer: A comprehensive global strategy for change
European Journal of Cancer · 2025-10-25 · 1 citations
Antibody drugs conjugates in small-cell lung cancer: present-day status and promises
The Oncologist · 2025-10-04
Antibody drugs conjugates in non–small cell lung cancer: current status and challenges
The Oncologist · 2025-10-04 · 6 citations
P2.02.09 Early-Stage Lung Adenocarcinoma: PLVAP-Driven Regulation of the Tumor Microenvironment
Journal of Thoracic Oncology · 2025-10-01
Journal of Thoracic Oncology · 2025-10-01
Journal of Thoracic Oncology · 2025-10-01
Cancer · 2025-08-26 · 2 citations
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity
Journal of Thoracic Oncology · 2025-08-05 · 11 citations
The Liberal Market as a Transition Case
2025-07-10
Political Keynesianism and the Managed Market
2025-07-10
2025-07-10
The Ambiguity of Economic Output
2025-07-10
The Lost Legitimacy and the Distributional Compulsion
2025-07-10
Introduction: The Argument in Brief
2025-07-10
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection
Nature Medicine · 2025-07-09 · 41 citations
Clinical Cancer Research · 2025-06-04 · 1 citations
Contrasting interferon-mediated antiviral responses in human lung adenocarcinoma cells
Journal of Virology · 2025-05-28
Journal of Clinical Oncology · 2025-05-28